60 likes | 77 Views
Global gram-positive bacterial infections market is expected to expand at a CAGR of 1.5% from 2018 to 2026. The market for gram-positive bacterial infections is expanding significantly, owing to an increase in the number of cases of gram-positive bacterial infections and a rapid rise in antibacterial resistance.
E N D
©2019 Transparency Market Research, All Rights Reserved Gram-positive Bacterial Infections Market Drug Type - Antibiotic (B-Lactam, Quinolones, Macrolides, Tetracyclines, Aminoglycosides, Sulfonamides, Phenicols), Antifungal; Disease - MRSA, Pneumonia, Sepsis, Sinusitis, Cellulitis, Otitis, Pharyngitis, Impetigo; Route of Administration - Enteral, Parenteral; Distribution Channel - Hospital Pharmacies, Drug Stores and Retail Pharmacies Forecast From 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter 1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Global Neurostimulation Devices Market, Key Insights Chapter 6 Global Gram-positive Bacterial Infections Market Analysis and Forecast, by Drug Type Chapter 7 Global Gram-positive Bacterial Infections Market Analysis and Forecast, by Disease Global Gram-positive Bacterial Infections Market Analysis and Forecast, by Route of Administration Chapter 8 Global Gram-positive Bacterial Infections Market Analysis and Forecast, by Distribution Channel Chapter 9 Chapter 10 Global Gram-positive Bacterial Infections Market Analysis and Forecast, by Region Chapter 11 North America Gram-positive Bacterial Infections Market Analysis and Forecast Chapter 12 Asia Pacific Gram-positive Bacterial Infections Market Analysis and Forecast Chapter 13 Latin America Gram-positive Bacterial Infections Market Analysis and Forecast Chapter 14 Middle East & Africa Gram-positive Bacterial Infections Market Analysis and Forecast Chapter 15 Competition Landscape
©2019 Transparency Market Research, All Rights Reserved Gram-positive Bacterial Infections Market: Snapshot • Gram-positive bacterial infection drugs act against gram-positive bacterial infections such as MRSA infections, sinusitis, and pneumonia. • Market for gram-positive bacterial infections is expanding significantly, owing to an increase in the number of cases of gram-positive bacterial infections and a rapid rise in antibacterial resistance. • Gram-positive bacterial infections market has been segmented based on drug type, disease, route of administration, distribution channel, and region. ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Reports Highlights • Global gram-positive bacterial infections market was valued at around US $ 51,450 Mn in 2017. It is expected to expand at a CAGR of 1.5% from 2018 to 2026. • Key Players – Bayer AG, Pfizer, Inc., Sanofi, GlaxoSmithkline plc (GSK), Merck & Co., Inc., AstraZeneca, Theravance Biopharma, Bristol-Myers Squibb Company, Novartis AG, and Allergan plc. ©2019 Transparency Market Research, All Rights Reserved Request Sample
©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U